PRME: Prime Medicine Inc

PRME新闻

• 15:24 Prime Medicine Stock Rallies Nearly 26% in a Month: Here's Why
• 15:54 Leading Indicators For The October Breakout Cycle
• 14:51 Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday
• 14:51 Humana、Evolution Metals & Technologies、Fastly 及其他大型股票周五上涨
• 17:05 周三盘中交易时段中12只医疗保健股异动上涨
• 17:05 12 Health Care Stocks Moving In Wednesday's Intraday Session
• 13:59 Apogee Enterprises公布乐观的第二季度财报，周二与Constellation Energy、Freshworks等其他大盘股一起走高
• 13:59 Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday
• 12:09 Prime Medicine宣布PM577a治疗威尔逊病的1/2期试验已完成首位患者给药；获得FDA罕见儿科疾病认定
• 12:09 Prime Medicine Announces First Patient Dosed In Phase 1/2 Trial Of PM577a In Wilson Disease; Receives FDA Rare Pediatric Disease Designation
• 13:00 Temporary Weakness in Intellia Stock Seems Like a Buying Opportunity
• 11:30 Beam Therapeutics: Ignore The Anthropic Noise And Focus On Clinical Progress (NASDAQ:BEAM)
• 20:00 Prime Medicine: A Buy Due To BLA Filing H1 '27 And In Vivo Therapy Development (PRME)
• 17:56 Prime Medicine Gets FDA Green Light for Gene Editing Study
• 08:40 Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
• 08:40 为什么INLIF股票交易价格上涨约78%？这里有20支正在盘前交易的股票
• 07:24 Costco Wholesale, Scholastic and 3 Stocks to Watch Heading Into Friday
• 07:24 好市多批发、斯科拉斯蒂克和3支周五值得关注的股票
• 21:05 12 Health Care Stocks Moving In Thursday's After-Market Session
• 21:05 周四盘后市场活跃的12家医疗保健股票
• 20:02 FDA Clears Prime Medicine’s IND Application For PM647, Investigational In Vivo Prime Editor For Alpha-1 Antitrypsin Deficiency
• 20:02 美国食品和药物管理局批准 Prime Medicine 公司的 PM647 IND 申请，用于治疗 Alpha-1 抗胰蛋白酶缺乏症的实验性原位 Prime 编辑治疗药物。
• 18:59 Crispr Therapeutics: Why AI Giant Anthropic's Discovery Has Rocked Gene Editing (CRSP)
• 17:35 10 Health Care Stocks Whale Activity In Today’s Session